Clinical features at transformation in adult T-cell leukemia–lymphoma with smoldering and chronic types
- 122 Downloads
Watchful waiting (WW) is among the treatment options indicated for patients with indolent adult T-cell leukemia–lymphoma (ATL). However, we previously showed that the long-term prognosis of patients with smoldering and chronic ATL is often worse than expected, with many undergoing transformation to aggressive ATL. To identify clinical features associated with transformation of smoldering/chronic ATL, we retrospectively analyzed the clinical features of 44 patients (14 smoldering and 30 chronic) who experienced transformation during WW. An elevated lactate dehydrogenase (LDH) value was most often observed (n = 30) at the time of transformation, especially in the chronic type (n = 24). Major organ involvement, lymphadenopathy, and hypercalcemia were shown to be associated with transformation in transformed patients without elevated LDH. The median overall survival time after transformation was only 7.8 months, and the prognosis was poor after transformation in those fulfilling the criteria of acute type, similar to that of de novo aggressive ATL. Laboratory data, such as LDH, and clinical signs including exacerbation of performance status, skin lesions, and lymphadenopathy should all be monitored during WW to ensure appropriate timing of chemotherapy initiation. Identification of optimal predictive markers for transformation and new therapeutic options is warranted to improve outcomes in indolent ATL.
KeywordsAdult T-cell leukemia–lymphoma (ATL) Transformation Smoldering Chronic
We thank the hematologists of the Department of Hematology, Nagasaki University Hospital, for their work in diagnosis and treatment of patients with ATL. KT was supported in part by Japan Agency for Medical Research and Development under Grant number JP18ck0106338.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 12.Yamada Y. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood. 1983;61:192–9.Google Scholar